前列腺癌:多焦点性质的分子方面,后果和机遇
Rolf I Skotheim1, Mari Bogaard2, Kristina T Carm3
1Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway; Department of Informatics, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway.
前列腺癌通常具有具有独特遗传特征的多个瘤,使诊断和治疗复杂化. 了解这种分子异质性是开发有效的预后测试和向治疗的关键.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 分子生物学分子生物学
背景情况:
- 前列腺癌经常出现多种不同的恶性焦点.
- 这种多焦点性质导致显著的分子异质性,挑战预后测试开发.
- 异质性对局部和晚期前列腺癌的管理策略产生影响.
研究的目的:
- 对初级前列腺癌的多区域基因组和转录基因组研究进行审查.
- 讨论介焦异质性对生物标志物发展和指标瘤定义的影响.
- 探索在前列腺癌治疗中管理分子异质性的策略.
主要方法:
- 使用多区域基因组学和转录基因组学现有研究的摘要.
- 在原发性前列腺癌中分析焦点间异质性.
- 考虑空间和时间变化的生物标志物发展的审查.
主要成果:
- 多区域分析揭示了瘤焦点之间的实质性体质突变和基因表达差异.
- 具有DNA损伤反应基因突变的前列腺癌对PARP抑制剂表现出敏感性.
- 异质性为开发准确的预后生物标志物和定义指数瘤带来了挑战.
结论:
- 开发预后生物标志物需要解决前列腺癌固有的分子异质性.
- 焦点治疗的概念需要对个别瘤焦点提供信息的生物标志物.
- 对于治疗决策,如激进前列腺切除术,需要异质性无关生物标志物或全器官信息生物标志物.
更多相关视频
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
13:19Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
相关概念视频
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Targeted Cancer Therapies
There are several types of targeted therapies against...
The Tumor Microenvironment
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
